title: Who benefits from drug discounts? Drugmakers, hospitals battle over indigent-care program.
authors.forename: Jaimy
authors.initials: J
authors.lastname: Lee
mesh_terms: D014487:Centers for Medicare and Medicaid Services, U.S. / Q000191:economics* / Q000331:legislation & jurisprudence; D017046:Cost Savings / Q000331:legislation & jurisprudence; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D004469:Economics, Hospital / Q000331:legislation & jurisprudence*; D018166:Health Care Reform / Q000191:economics / Q000458:organization & administration; D006801:Humans; D055553:Prescription Drugs / Q000191:economics*; D017664:Uncompensated Care / Q000191:economics* / Q000331:legislation & jurisprudence; D014481:United States
chemical_list: D055553:Prescription Drugs